Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Mar, 25 2026
Feb, 28 2025
Aug, 4 2025
Mar, 19 2026
Dec, 4 2025